Trials / Recruiting
RecruitingNCT06092814
tACS to Enhance Language Abilities
Transcranial Alternating Current Stimulation (tACS) to Enhance Language Abilities
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke aphasia. Participants will receive real and sham tACS in conjunction with various language tests. Researchers will compare the post-stroke aphasia group with aged matched controls to see if brain response to tACS differs between groups.
Detailed description
This research will investigate whether transcranial alternating current stimulation (tACS), a form of noninvasive brain stimulation, can be used to enhance language abilities in people with aphasia (PWA) due to stroke and healthy older adults when compared to placebo (sham) tACS. The investigators hypothesize that alpha vs. sham tACS will improve language abilities. In addition, the investigators propose that alpha vs. sham tACS will increase local alpha power as well as alpha-induced functional connectivity, and the degree to which alpha tACS increases will be related to the degree of language performance improvement. Finally, the investigators hypothesize that PWA will exhibit abnormalities in alpha-related activity when compared to matched controls, and aphasia severity will be associated with the degree of PWA dysfunction in alpha power and alpha-driven functional connectivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active transcranial alternating current stimulation (tACS) | Transcranial Alternating Current Stimulation (tACS) is a device that applies a low-intensity electrical current to the brain through electrodes on the scalp. |
Timeline
- Start date
- 2024-07-12
- Primary completion
- 2028-08-31
- Completion
- 2028-08-31
- First posted
- 2023-10-23
- Last updated
- 2025-08-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06092814. Inclusion in this directory is not an endorsement.